Accelerating Discoveries Toward Better Health
The North Carolina Translational and Clinical Sciences (NC TraCS) Institute, the integrated home of the Clinical and Translational Science Awards (CTSA) program at UNC-CH, is supported through the National Institutes of Health (NIH), grant 1UL1TR001111. The CTSA program is led by the NIH’s National Center for Advancing Translational Sciences (NCATS).
The NC TraCS Institute is one of 62 CTSA medical research institutions, a national consortium to improve the way biomedical research is conducted across the country.
As of 2013, NC TraCS combines the research strengths, resources and opportunities of the University of North Carolina at Chapel Hill (UNC), its new partner RTI International (RTI) and planning partner North Carolina Agricultural and Technical State University (N.C. A&T) to accelerate clinical and translational research from health science discovery to dissemination to patients and communities. NC TraCS seeks to overcome barriers to translation by improving efficiency, training the research workforce and sharing successful, validated research methods.
NC TraCS aims to:
- Expand to support the full spectrum of clinical and translational research.
- Focus on three strategic initiatives: next-generation technologies to transform clinical research and practice, new paradigms and resources to accelerate drug development, and comparative-effectiveness research to provide definitive evidence of the benefits and harms of tests and treatments.
- Train, support and motivate the next generation of clinical and translational researchers.
The unique research and training resources at NC TraCS will support the full range of clinical and translational research, from basic science to clinical application to policy change, to benefit patients across the state and nationally through the CTSA Consortium.